Spots Global Cancer Trial Database for astrocytoma, grade iv
Every month we try and update this database with for astrocytoma, grade iv cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma | NCT03072134 | Glioma Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... Glioblastoma Mu... Astrocytoma, Gr... Astrocytoma, Gr... Brain Cancer | Neural stem cel... | 18 Years - | Northwestern University | |
| Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma | NCT04757662 | Grade III Astro... Grade IV Astroc... Astrocytoma, Gr... Astrocytoma, Gr... | Tadalafil | 18 Years - | Washington University School of Medicine | |
| Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM | NCT00943462 | Astrocytoma, Gr... Giant Cell Glio... Glioblastoma Mu... | External-beam r... Temozolomide | 18 Years - 70 Years | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | NCT03956706 | Glioblastoma Astrocytoma, Gr... Astrocytoma, Gr... Malignant Gliom... | Stereotactic Ra... | 18 Years - | Northwell Health | |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) | NCT02766699 | Glioblastoma Astrocytoma, Gr... | EGFR(V)-EDV-Dox | 18 Years - | Engeneic Pty Limited | |
| CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type | NCT05218408 | Astrocytoma, Gr... Glioblastoma Giant Cell Glio... Glioblastoma Mu... | CYNK-001 system... | 18 Years - | Celularity Incorporated | |
| Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma | NCT02510950 | Glioblastoma Mu... Astrocytoma, Gr... | Personalized pe... Poly-ICLC Temozolomide | 18 Years - | Washington University School of Medicine | |
| Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma | NCT02709226 | Astrocytoma, Gr... Giant Cell Glio... Glioblastoma Mu... Gliosarcoma | Radiation | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | NCT03956706 | Glioblastoma Astrocytoma, Gr... Astrocytoma, Gr... Malignant Gliom... | Stereotactic Ra... | 18 Years - | Northwell Health | |
| BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels | NCT05375318 | Astrocytoma, Gr... Glioblastoma Glioblastoma Mu... Glioblastoma, I... Glioblastoma, I... Glioblastoma ID... Glioblastoma ID... High Grade Glio... | 18 Years - | Universitat Politècnica de València | ||
| Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma | NCT02510950 | Glioblastoma Mu... Astrocytoma, Gr... | Personalized pe... Poly-ICLC Temozolomide | 18 Years - | Washington University School of Medicine | |
| Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma | NCT04757662 | Grade III Astro... Grade IV Astroc... Astrocytoma, Gr... Astrocytoma, Gr... | Tadalafil | 18 Years - | Washington University School of Medicine | |
| The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) | NCT06118723 | Glioblastoma High-grade Glio... Glioblastoma, I... Glioblastoma, I... Glioblastoma Mu... Astrocytoma, Gr... Astrocytoma, Gr... Astrocytoma, Ma... Brain Neoplasms Brain Neoplasm,... Brain Neoplasms... Brain Neoplasm,... | Supramaximal re... Maximal safe re... | 18 Years - 90 Years | Erasmus Medical Center | |
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM | NCT04489420 | Astrocytoma, Gr... Giant Cell Glio... Glioblastoma Mu... Cyclophosphamid... Immunosuppressi... Immunologic Fac... Physiological E... Molecular Mecha... Antiviral Agent... Anti-infective ... Analgesics, Non... Analgesics Sensory System ... Peripheral Nerv... | CYNK001-IV CYNK001-IT | 18 Years - | Celularity Incorporated | |
| The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) | NCT06118723 | Glioblastoma High-grade Glio... Glioblastoma, I... Glioblastoma, I... Glioblastoma Mu... Astrocytoma, Gr... Astrocytoma, Gr... Astrocytoma, Ma... Brain Neoplasms Brain Neoplasm,... Brain Neoplasms... Brain Neoplasm,... | Supramaximal re... Maximal safe re... | 18 Years - 90 Years | Erasmus Medical Center | |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) | NCT02766699 | Glioblastoma Astrocytoma, Gr... | EGFR(V)-EDV-Dox | 18 Years - | Engeneic Pty Limited | |
| DC Migration Study for Newly-Diagnosed GBM | NCT02366728 | Glioblastoma Astrocytoma, Gr... Giant Cell Glio... Glioblastoma Mu... | Unpulsed DCs Td Human CMV pp65-... 111In-labeled D... Temozolomide Saline Basiliximab | 18 Years - 80 Years | Duke University | |
| Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection | NCT01240460 | Glioblastoma Astrocytoma, Gr... | XL765 (SAR24540... XL147 (SAR24540... | 18 Years - | Sanofi | |
| ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas | NCT05229198 | Astrocytoma, Gr... | 18 Years - | Universitat Politècnica de València | ||
| CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type | NCT05218408 | Astrocytoma, Gr... Glioblastoma Giant Cell Glio... Glioblastoma Mu... | CYNK-001 system... | 18 Years - | Celularity Incorporated | |
| ALBATROSS Study: International Multicenter Study for Prospective Validation of Imaging Biomarkers Calculated at Vascular Habitats of High-grade Gliomas | NCT05229198 | Astrocytoma, Gr... | 18 Years - | Universitat Politècnica de València | ||
| The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. | NCT03861299 | Glioblastoma Glioblastoma Mu... Glioblastoma Mu... Astrocytoma, Gr... Brain Tumor Brain Cancer Brain Neoplasms | Awake craniotom... Craniotomy unde... | 18 Years - 90 Years | Erasmus Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
